List of Figures
Figure 1: Immunology Drugs Market, 7MM, Epidemiology Patterns for Rheumatoid Arthritis, 2016–2023 28
Figure 2: Immunology Drugs Market, 7MM, Epidemiology Patterns for Psoriasis, 2016–2023 29
Figure 3: Immunology Drugs Market, 7MM, Epidemiology Patterns for Crohn’s Disease, 2016–2023 30
Figure 4: Immunology Drugs Market, Epidemiology Patterns for Ulcerative colitis, 2016–2023 30
Figure 5: Immunology Drugs Market, Epidemiology Patterns for Graft Versus Host Disease, 2016–2023 31
Figure 6: Immunology Drugs Market, Global, Key Marketed Products and Approved Indications, 2018 40
Figure 7: Immunology Drugs Market, Global, Annual Revenues for Humira ($bn), 2006–2023 43
Figure 8: Immunology Drugs Market, Global, Annual Revenue for Enbrel ($bn), 2006–2023 45
Figure 9: Immunology Drugs Market, Global, Annual Revenue for Remicade ($bn), 2006–2023 48
Figure 10: Immunology Drugs Market, Global, Annual Revenue for Rituxan ($bn), 2006–2023 50
Figure 11: Immunology Therapeutics Market, Global, Annual Revenue for Stelara ($bn), 2010–2023 52
Figure 12: Immunology Drugs Market, Global, Annual Revenue for Simponi ($bn), 2010–2023 54
Figure 13: Immunology Drugs Market, Global, Annual Revenue for Orencia ($bn), 2006–2023 56
Figure 14: Immunology Drugs Market, Global, Annual Revenue for Tysabri ($bn), 2006–2023 58
Figure 15: Immunology Drugs Market, Global, Annual Revenues for Actemra ($bn), 2006–2023 60
Figure 16: Immunology Drugs Market, Global, Annual Revenue for Prograf ($bn), 2006–2023 62
Figure 17: Immunology Drugs Market, Global, Annual Revenue for Cimzia ($bn), 2008–2023 63
Figure 18: Immunology Drugs Market, Global, Annual Revenue for Entyvio ($bn), 2014–2023 65
Figure 19: Immunology Drugs Market, Global, Annual Revenue for Cosentyx ($bn), 2015–2023 66
Figure 20: Immunology Drugs Market, Global, Annual Revenue for Otezla($bn), 2014–2023 68
Figure 21: Immunology Drugs Market, Global, Annual Revenues for Xeljanz ($bn), 2012–2023 70
Figure 22: Immunology Drugs Market, Global, Annual Revenue for Taltz ($bn), 2016–2023 71
Figure 23: Immunology Drugs Market, Global, Overall Pharmaceutical Industry Pipeline by Therapy Area, 2018 72
Figure 24: Immunology Drugs Market, Global, Pipeline by Stage of Development and Molecule Type, 2018 73
Figure 25: Immunology Drugs Market, Global, Pipeline by Program Type, 2018 74
Figure 26: Immunology Drugs Market, Global, Pipeline for Key Immunology Indications by Stage of Development, 2018 75
Figure 27: Immunology Drugs Market, Global, Pipeline for Key Immunology Indications by Molecule Type, 2018 76
Figure 28: Immunology Drugs Market, Pipeline by Molecular Target, 2018 78
Figure 29: Immunology Drugs Market, Global, Pipeline for Key Immunology Indications by Molecular Target, 2018 79
Figure 30: Immunology Drugs Market, Global, Clinical Trial Failure Rates and Overall Clinical Trial Attrition Rate by Stage of Development (%), 2006–2018 80
Figure 31: Immunology Drugs Market, Global, Clinical Trial Failure Rates by Key Indication and Stage of Development (%), 2006–2017 81
Figure 32: Immunology Drugs Market, Global, Clinical Trial Failure Rates by Molecule Type and Stage of Development (%), 2006–2017 81
Figure 33: Immunology Drugs Market, Global, Clinical Trial Failure Rates by Molecular Target and Stage of Development (%), 2006–2017 82
Figure 34: Immunology Drugs Market, Global, Clinical Trial Duration by Stage of Development (months), 2006–2017 83
Figure 35: Immunology Drugs Market, Global, Clinical Trial Duration by Key Indication and Stage of Development (months), 2006–2017 84
Figure 36: Immunology Drugs Market, Global, Clinical Trial Duration by Molecule Type and Stage of Development (months), 2006–2017 85
Figure 37: Immunology Drugs Market, Global, Clinical Trial Duration by Molecular Target and Stage of Development (months), 2006–2017 86
Figure 38: Immunology Drugs Market, Global, Clinical Trial Size by Stage of Development (participants), 2006–2017 86
Figure 39: Immunology Drugs Market, Global, Clinical Trial Size by Key Indication and Stage of Development (participants), 2006–2017 87
Figure 40: Immunology Drugs Market, Global, Clinical Trial Size by Stage of Development and Molecule Type (participants), 2006–2017 88
Figure 41: Immunology Drugs Market, Global, Clinical Trial Size by Molecular Target and Stage of Development (participants), 2006–2017 89
Figure 42: Immunology Drugs Market, Global, Clinical Program Size by Stage of Development (participants), 2006–2017 90
Figure 43: Immunology Drugs Market, Global, Clinical Program Size by Key Indication and Stage of Development (participants), 2006–2017 91
Figure 44: Immunology Drugs Market, Global, Clinical Program Size by Molecule Type and Stage of Development (participants), 2006–2017 92
Figure 45: Immunology Drugs Market, Global, Clinical Program Size by Molecular Target and Stage of Development (participants), 2006–2017 93
Figure 46: Immunology Drugs Market, Global, Annual Revenue Forecast for Filgotinib ($m), 2019–2023 94
Figure 47: Immunology Drugs Market, Global, Annual Revenue Forecast for AR-101 ($m), 2019–2023 95
Figure 48: Immunology Drugs Market, Global, Annual Revenue Forecast for Upadacitinib ($m), 2019–2023 96
Figure 49: Immunology, Global, Annual Revenue Forecast for Lanadelumab ($m), 2018–2023 98
Figure 50: Immunology Drugs Market, Global, Annual Revenue Forecast for Ozanimod ($m), 2018–2023 99
Figure 51: Immunology Drugs Market, Global, Annual Revenue Forecast for Risankizumab ($m), 2018–2023 100
Figure 52: Immunology Drugs Market, Global, Market Size ($bn), 2016–2023 102
Figure 53: Immunology Drugs Market, Global, Annual Revenue Forecast for Premium and Generic Products ($bn), 2016–2023 104
Figure 54: Immunology Drugs Market, Global, Annual Revenue Forecast for Cytokines and Cytokine Receptors ($bn), 2016–2023 107
Figure 55: Immunology Drugs Market, Global, Annual Revenue Forecast for Intracellular Signal Transducers ($bn), 2016–2023 108
Figure 56: Immunology Drugs Market, Global, Annual Revenue Forecast for Cell Surface Antigens ($bn), 2016–2023 109
Figure 57: Immunology Drugs Market, Global, Annual Revenue Forecast for Intercellular Interaction and Adhesion Molecules ($bn), 2016–2023 110
Figure 58: Immunology Drugs Market, Global, Company Analysis Matrix, 2016–2023 111
Figure 59: Immunology Drugs Market, Global, Cluster by Growth and Market Share, 2016–2023 112
Figure 60: Immunology Drugs Market, Global, Forecast Market Share by Company (%), 2016–2023 116
Figure 61: Immunology Drugs Market, Global, Companies by Compound Annual Growth Rate (%), 2016–2023 117
Figure 62: Immunology Drugs Market, Global, Revenues by Route of Acquisition, 2016–2023 118
Figure 63: Immunology Drugs Market, Global, AbbVie, Annual Revenue Forecast ($bn), 2016–2023 119
Figure 64: Immunology Drugs Market, Global, Johnson & Johnson, Annual Revenue Forecast ($bn), 2016–2023 120
Figure 65: Immunology Drugs Market, Global, Novartis Annual Revenue Forecast ($bn), 2016–2023 121
Figure 66: Immunology Drugs Market, Global, Pfizer, Annual Revenue Forecast ($bn), 2016–2023 123
Figure 67: Immunology Drugs Market, Global, Roche Annual Revenue Forecast ($bn), 2016–2023 124
Figure 68: Immunology Drugs Market, Global, Amgen, Annual Revenue Forecast ($bn), 2016–2023 125
Figure 69: Immunology Drugs Market, Global, Celgene, Annual Revenue Forecast ($bn), 2016–2023 126
Figure 70: Immunology Drugs Market, Global, Eli Lilly, Annual Revenue Forecast ($bn), 2016–2023 127
Figure 71: Immunology Drugs Market, Global, High-Activity and Late-Stage Pipeline Developers by Company Type, 2018 128
Figure 72: Immunology Drugs Market, Global, Pipeline, High-Activity and Late-Stage Pipeline Developers by Level of Specialization, 2018 129
Figure 73: Immunology Drugs Market, Global, Proportion of Total Company Revenue Attributed to Immunology Disorders, 2016–2023 130
Figure 74: Immunology Drugs Market, Global, Licensing Deals by Region, Year and Value, 2006–2018 132
Figure 75: Immunology Drugs Market, Global, Licensing Deals by Key Indication, 2006–2018 133
Figure 76: Immunology Market, Global, Licensing Deals by Stage of Development, 2006–2018 133
Figure 77: Immunology Drugs Market, Global, Licensing Deals by Molecule Type and Molecular Target, 2006–2018 134
Figure 78: Immunology Drugs Market, Global, Licensing Deals with Disclosed Values, 2006–2018 (part 1) 135
Figure 79: Immunology Drugs Market, Global, Licensing Deals with Disclosed Values, 2006–2018 (part 2) 136
Figure 80: Immunology Drugs Market, Global, Licensing Deals with Disclosed Values, 2006–2018 (part 3) 137
Figure 81: Immunology Drugs Market, Global, Licensing Deals with Disclosed Values, 2006–2018 (part 4) 138
Figure 82: Immunology Drugs Market, Global, Co-development Deals by Region, Year and Value, 2006–2018 139
Figure 83: Immunology Drugs Market, Global, Co-development Deals by Key Indication, 2006–2018 140
Figure 84: Immunology Drugs Market, Global, Co-development Deals by Stage of Development, 2006–2018 140
Figure 85: Immunology Drugs Market, Global, Co-development Deals by Molecule Type and Molecular Target, 2006–2018 141
Figure 86: Immunology Drugs Market, Global, Co-development Deals with Disclosed Values, 2006–2018 (part 1) 142
Figure 87: Immunology Drugs Market, Global, Co-development Deals with Disclosed Values, 2006–2018 (part 2) 143
Figure 88: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 1 157
Figure 89: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 2 158
Figure 90: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 3 159
Figure 91: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 4 160
Figure 92: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 5 161
Figure 93: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 6 162
Figure 94: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 7 163
Figure 95: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 8 164
Figure 96: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 9 165
Figure 97: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 10 166
Figure 98: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 11 167
Figure 99: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 12 168
Figure 100: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 13 169
Figure 101: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 14 170
Figure 102: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 15 171
Figure 103: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 16 172
Figure 104: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 17 173
Figure 105: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 18 174
Figure 106: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 19 175
Figure 107: Immunology Drugs Market, Global, Table of all Clinical Stage Pipeline Products, 2018, Part 20 176